Loading patent…
AssigneeEuropean Molecular Biology Laboratory
InventorsPaul HEPPENSTALL, Mariano MAFFEI, Fernada DE CASTRO REIS, Kanyn Morris POUW
Estimating the term…
The present invention relates to improved adeno-associated virus (AAV) particles for gene delivery and gene therapy. Provided are adeno associated virus (AAV) particles that comprise a modified capsid. The present invention further relates to methods for producing the improved AAV particles of this invention by removing natural binding sites in adeno associated virus (AAV) capsids and introducing ligand binding sites into said capsid to provide AAVs that transduce only particular cells of interest. An additional aspect of the present invention relates to modified AAV particles for use in the treatment of a disease and methods for treating a disease, comprising administering the modified AAV particles to a subject in need thereof. Yet a further aspect of this invention relates to the AAV particles of this invention for the transfection of cells, for example as a gene delivery tool in basic research.
1-16. (canceled)
An adeno associated virus (rAAV) particle comprising a chemically modified capsid protein, wherein the chemically modified capsid protein comprises one or more of a ligand binding site;
A method of producing an adeno associated virus (rAAV) particle comprising a chemically modified capsid protein, the method comprising the steps of:
Dependencies are inferred from the claim text.